Preliminary study on the antinociceptive effect of elephant beta-endorphin.
1. Intraventricular administration of human beta-endorphin and elephant beta-endorphin significantly prolonged the tail flick response tested 30 min later. However, elephant beta-endorphin was about 7-8 times more potent than human beta-endorphin in the tail flick test. 2. beta-Endorphin antagonized the antinociceptive effect of both human beta-endorphin and elephant beta-endorphin by the same extent. Naloxone also antagonized the antinociceptive effects of the beta-endorphins but it was less effective than beta-endorphin. 3. Human beta-endorphin and elephant beta-endorphin were of equal potency in inhibiting the abdominal constriction response induced by intraperitoneal (i.p.) acetic acid. Both beta-endorphin and naloxone antagonized these effects of the beta-endorphins with naloxone being more effective. 4. The present study showed that different opioid receptor subtypes may be involved in the tail flick test and the abdominal constriction test. Furthermore, elephant beta-endorphin was a better antinociceptive agent than human beta-endorphin in the tail flick test.
Wong
C L
CL
Department of Pharmacology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, NT.
Wai
M K
MK
Cheng
H C
HC
Chung
D
D
Yamashiro
D
D
D000700:Analgesics; D000818:Animals; D004606:Elephants; D006801:Humans; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009270:Naloxone / Q000494:pharmacology; D010147:Pain Measurement / Q000379:methods; D010446:Peptide Fragments / Q000494:pharmacology; D001615:beta-Endorphin / Q000494:pharmacology*
D000700:Analgesics; D010446:Peptide Fragments; D009270:Naloxone; D001615:beta-Endorphin; C035581:beta-endorphin (1-27)